Quest Laboratories Limited (NSE:QUESTLAB)
India · Delayed Price · Currency is INR 99.90
0.00 (0.00%)
At close: Aug 8, 2025
Verve Therapeutics Revenue
Quest Laboratories had revenue of 231.85M INR in the quarter ending June 30, 2025, with 13.19% growth. This brings the company's revenue in the last twelve months to 1.12B, up 44.68% year-over-year. In the fiscal year ending March 31, 2025, Quest Laboratories had annual revenue of 1.04B with 25.86% growth.
Revenue (ttm)
1.12B
Revenue Growth
+44.68%
P/S Ratio
1.46
Revenue / Employee
15.11M
Employees
74
Market Cap
1.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.04B | 213.52M | 25.86% |
| Mar 31, 2024 | 825.63M | 209.22M | 33.94% |
| Mar 31, 2023 | 616.41M | 21.57M | 3.63% |
| Mar 31, 2022 | 594.84M | 291.20M | 95.91% |
| Mar 31, 2021 | 303.63M | 39.84M | 15.10% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |